Impact of framing scheme optimization and smoking status on binding potential analysis in dynamic PET with [
Framing scheme
Non-displaceable binding potential
PET
Quantification bias
Schizophrenia
Smoking status
mGluR5
Journal
EJNMMI research
ISSN: 2191-219X
Titre abrégé: EJNMMI Res
Pays: Germany
ID NLM: 101560946
Informations de publication
Date de publication:
09 Feb 2023
09 Feb 2023
Historique:
received:
19
12
2022
accepted:
24
01
2023
entrez:
9
2
2023
pubmed:
10
2
2023
medline:
10
2
2023
Statut:
epublish
Résumé
For positron emission tomography (PET) ligands, such as [ When applying F-tests to the 'Const 5 min' framing scheme, effect sizes (η Based on an [
Sections du résumé
BACKGROUND
BACKGROUND
For positron emission tomography (PET) ligands, such as [
RESULTS
RESULTS
When applying F-tests to the 'Const 5 min' framing scheme, effect sizes (η
CONCLUSIONS
CONCLUSIONS
Based on an [
Identifiants
pubmed: 36757553
doi: 10.1186/s13550-023-00957-8
pii: 10.1186/s13550-023-00957-8
pmc: PMC9911569
doi:
Types de publication
Journal Article
Langues
eng
Pagination
11Subventions
Organisme : Deutsche Forschungsgemeinschaft
ID : 491111487
Organisme : FP7 Health
ID : 602621
Organisme : FP7 Health
ID : 602621
Informations de copyright
© 2023. The Author(s).
Références
Psychiatry Res. 2016 Dec 30;246:1-8
pubmed: 27639816
Synapse. 2018 Sep;72(9):e22041
pubmed: 29935121
Nuklearmedizin. 2011;50(2):74-82
pubmed: 21286660
PLoS One. 2021 Jan 22;16(1):e0245580
pubmed: 33481896
Proc Natl Acad Sci U S A. 2013 Jan 8;110(2):737-42
pubmed: 23248277
EJNMMI Phys. 2014 Jul;1(Suppl 1):A47
pubmed: 26501635
Compr Psychiatry. 2010 Mar-Apr;51(2):106-9
pubmed: 20152288
Transl Psychiatry. 2022 Jan 10;12(1):6
pubmed: 35013095
Schizophr Res. 2005 Jul 15;76(2-3):135-57
pubmed: 15949648
EJNMMI Phys. 2020 May 12;7(1):31
pubmed: 32399664
Hum Brain Mapp. 2020 Jul;41(10):2762-2781
pubmed: 32150317
Transl Psychiatry. 2018 Jan 10;8(1):17
pubmed: 29317611
Aust N Z J Psychiatry. 2009 Mar;43(3):277-82
pubmed: 19221917
Phys Med Biol. 2008 Jun 21;53(12):3217-30
pubmed: 18506070
Psychiatry Res. 2005 Nov 15;137(1-2):137-41
pubmed: 16225931
Eur J Nucl Med Mol Imaging. 2009 Oct;36(10):1639-50
pubmed: 19437012
Ann N Y Acad Sci. 2012 Feb;1248:89-106
pubmed: 22129082
Hum Brain Mapp. 2003 Aug;19(4):224-47
pubmed: 12874777
Front Neurol. 2020 Feb 07;11:1
pubmed: 32116995
J Cereb Blood Flow Metab. 2017 Aug;37(8):2716-2727
pubmed: 27742888
Schizophr Res. 2017 May;183:95-101
pubmed: 27847228
Biol Psychiatry. 2015 Feb 1;77(3):266-275
pubmed: 25156701
Phys Med Biol. 2007 Apr 21;52(8):2089-106
pubmed: 17404457
EJNMMI Phys. 2020 Jan 10;7(1):2
pubmed: 31925574
Ther Adv Psychopharmacol. 2019 Jul 01;9:2045125319859969
pubmed: 31308936
Eur J Nucl Med Mol Imaging. 2016 Jan;43(1):152-162
pubmed: 26290423
AJR Am J Roentgenol. 2019 Aug;213(2):W50-W56
pubmed: 30995096
Neuroimage. 1996 Dec;4(3 Pt 1):153-8
pubmed: 9345505
Annu Int Conf IEEE Eng Med Biol Soc. 2022 Jul;2022:234-237
pubmed: 36086347
Schizophr Res. 2009 Feb;107(2-3):192-7
pubmed: 19006656
IEEE Trans Med Imaging. 2015 Jan;34(1):126-36
pubmed: 25137726
Biol Psychiatry. 2016 Mar 15;79(6):474-80
pubmed: 25861697
Schizophr Res. 2009 Oct;114(1-3):91-7
pubmed: 19656658